Emergency Endoscopic Variceal Ligation versus Somatostatin for Acute Esophageal Variceal Bleeding

BackgroundEndoscopic variceal ligation and somatostatin are widely used for treating acute esophageal variceal bleeding. This study compared the efficacy, safety, and survival of both therapies.MethodsAcute esophageal variceal bleeding patients were randomized to undergo emergency ligation or receive a bolus of 250 μg somatostatin plus infusion at 250 μg/hour for 48 hours and undergo ligation subsequently.ResultsThree (4.8%) of 62 patients in the ligation group and 20 (31.7%) of 63 patients in the somatostatin group encountered treatment failure (p = 0.0001). Transfusion requirements were 4.7 ± 3.2 units in the ligation group and 6.9 ± 7.3 units in the somatostatin group (p = 0.03). Hospital stay was 7.7 ± 4.0 days in the ligation group and 10.2 ± 9.9 days in the somatostatin group (p = 0.07). Adverse effects occurred in the ligation group (20 episodes) and the somatostatin group (27 episodes) (p = 0.2). The 42-day mortality rates were 5 patients (8.1%) in the ligation group and 3 patients (4.8%) in the somatostatin group (p = 0.5).ConclusionEmergency ligation was superior to somatostatin in treating acute esophageal variceal bleeding, with fewer requirements of transfusion and a tendency toward shorter hospital stay. The adverse effects and 42-day mortality rates were similar between both treatments.